Annovis Bio after-hours gains 3.76% following investor webcast on late-stage clinical programs.

Tuesday, Jun 25, 2024 5:17 pm ET1min read
Annovis Bio after-hours gains 3.76% following investor webcast on late-stage clinical programs.

Comments



Add a public comment...
No comments

No comments yet